Skip to content
Home/Companies/Healthcare/ACT Lab
ACT Lab

ACT Lab

Healthcare·US·Active·New
Entry
2026
Hold
New
Status
Active

Who owns ACT Lab?

ACT Lab has Claret Capital Partners on file as a lender through Claret European Growth Capital Fund IV (2025 vintage), financing since 2026. Its equity owner is not tracked by GP Intel yet.

Hand-verified · updated 2026-07-17

Claret Capital Partners
Investor
Claret Capital Partners
Claret European Growth Capital Fund IV · 2025 · Private Debt

Key facts

HQUnited States
SectorHealthcare
StatusActive
Websiteact-lab.com

More from Claret European Growth Capital Fund IV

Other portfolio companies in the same fund.

Cinclus Pharma
Cinclus Pharma
Active
PharmaSweden· 2026
Inventiva
Inventiva
Active
BiotechFrance· 2026
Deciphex
Deciphex
Active
MedTechIreland· 2025
Fund Recs
Fund Recs
Active
FintechIreland· 2025
Mindler
Mindler
Active
HealthTechSweden· 2025
Montonio
Active
FintechEstonia· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track ACT Lab

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy ACT Lab?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on ACT Lab.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue